Thanks for your thoughtful input, @ptribble ๐Ÿ‘‹

You're right โ€” JavaFX doesnโ€™t target every platform, but it covers the major ones well:
โœ… Linux
โœ… macOS
โœ… Windows
โœ… iOS
โœ… Android
โœ… Web

No framework truly runs everywhere, yet JavaFX offers strong cross-platform reach. The key now is community growth and ecosystem evolution โ€” and itโ€™s happening! ๐Ÿ’ช

#JavaFX #Java #Gluon #JPro #OpenJDK #CrossPlatform #DesktopDev #MobileDev

@CommonGround_2048 Thanks for mentioning #WebFX ๐Ÿ™
Iโ€™m aware of it but havenโ€™t tried it yet in a real project.

Indeed, #JavaFX is truly cross-platform โ€” running across #Windows, #Linux, #macOS, #Android, #iOS, and #Web.

Iโ€™ll definitely explore #WebFX soon.
Right now, Iโ€™m focusing on building and testing for #iPhone and #macOS โ€” using both the classic #JavaFXMobile-plugin and the latest #GluonFX toolchain.

#JPro is already working great for me ๐Ÿš€

๐Ÿš€ The real power of #Java & #JavaFX is not just Desktop (Windows, Linux, macOS) โ€” but true cross-platform:
๐Ÿ–ฅ๏ธ Desktop (Win/Linux/macOS)
๐Ÿ“ฑ Mobile (Android/iOS)
๐ŸŒ Web
โš™๏ธ Embedded devices

With @gluonhq (GluonFX, Substrate, Attach, VMOne, GraalVM) & @jpro, this vision is reality โ€” powered by #OpenJDK + #OpenJFX.

#JavaEverywhere #Java #JavaFX #CrossPlatform #MobileDev #WebDev #GluonHQ #JPro

How to select relevant items for monitoring? Case example of a pragmatic process for mapping immune checkpoint inhibitor #SideEffects to items from existing item libraries ( #CTCAE #EORTC #FACIT )
https://jpro.springeropen.com/articles/10.1186/s41687-025-00855-8

#HRQL #JPRO #PatientCentered #PatientReported #ePRO

Mapping immune checkpoint inhibitor side effects to item libraries for use in real-time side effect monitoring systems - Journal of Patient-Reported Outcomes

Background Monitoring for the side effects of novel therapies using patient-reported outcomes (PROs) is critical for ensuring patient safety. Existing static patient-reported outcome measures may not provide adequate coverage of novel side effects. Item libraries provide a flexible approach to monitoring for side effects using customized item lists, but the ideal process for matching side effects to items sourced from multiple item libraries is yet to be established. We sought to develop a pragmatic process for mapping side effects to items from three major item libraries using immune checkpoint inhibitor (ICI) side effects as an example. Methods Using a consumer- and clinician-driven list of 36 ICI side effects, two authors independently mapped side effects to Common Terminology Criteria for Adverse Event (CTCAE) terms, and then to three item libraries: the Patient-Reported Outcome version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), the European Organisation for Research and Treatment of Cancer (EORTC) Item Library, and the Functional Assessment of Chronic Illness Therapy (FACIT) searchable library. The rates of inter-rater agreement were recorded. Following item collation from the item libraries, we devised criteria for selecting the optimal item for each side effect for inclusion in a future electronic PRO system based on guidance from the above groups. Results All 36 side effects mapped to at least one CTCAE term, with eight mapping to more than one term. Twenty-three side effects mapped to at least one PRO-CTCAE term, 35 side effects mapped to at least one EORTC item, and 31 side effects mapped to at least one FACIT item. The inter-rater agreement rate was 100% (PRO-CTCAE), 83% (EORTC) and 75% (FACIT). Pre-determined criteria were applied to select the optimal item for each side effect from the three item libraries, producing a final 61-item list. Conclusion Using ICI side effects as an example, we developed a pragmatic approach to creating customized item lists from three major item libraries to monitor for side effects of novel therapies in routine care. This process highlighted the challenges of using item libraries and priorities for future work to improve their usability.

SpringerOpen

Monday programme at #ISOQOL starting with the official opening and president's address.

The conference abstracts have been published just in time:
https://link.springer.com/article/10.1007/s11136-024-03786-x

Today, I'll chair my last QLR board meeting and Oral Session 109 on guidelines and good practices.

For the evening #ISOQOL_NewInvestigators kindly invited me and #JPRO Rasa Ruseckaite to present on manuscript writing.

I am looking forward to meeting my 2024 mentees at the #Mentoring reception.

Edit:
#HRQL #HealthEconomics

31st Annual Conference of the International Society for Quality of Life Research - Quality of Life Research

SpringerLink